Insomnia
📧 Sign up to get email alerts when something new happens for Insomnia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-03-31Clinical Trial Update: Individualized Treatment With Traditional Chinese Medicine for the Patients With Insomnia Disorder: a Cohort Study
This document reports a clinical trial update for an observational cohort study evaluating individualized Traditional Chinese Medicine for i…
-
FDA approval · 2015-03-19FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for zolpidem tartrate submitted by NorthStar Rx LLC, resulting in approval of an additional zolpidem…
-
FDA approval · 2015-03-19FDA Approved: ESZOPICLONE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for a generic eszopiclone product, confirming approval to market a generic vers…
-
FDA approval · 2015-03-19FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for zolpidem tartrate, expanding the approved formulation/use for treating insomnia.
-
FDA approval · 2015-03-19FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for zolpidem tartrate from Sandoz Inc, approving changes to an existing generic product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-03-19FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for Zolpidem Tartrate from Lupin Pharmaceuticals, Inc., approving a generic zolpidem tartrate produc…
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: Efficacy and Safety of Temazepam in HIV Seropositive Patients With Insomnia [Phase 4]
Phase 4 results evaluate the efficacy and safety of temazepam for treating insomnia in HIV-positive individuals.
-
FDA approval · 2015-03-06FDA Approved: ULTRA SLEEP AID — Supplemental Application (Walgreen Company)
The FDA approved a supplemental application for ULTRA SLEEP AID containing doxylamine succinate, submitted by Walgreens Company. This action…
-
FDA approval · 2015-02-27FDA Approved: ESZOPICLONE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for eszopiclone filed by Dr. Reddy's Laboratories Limited, approving a generic version of the sl…
-
FDA approval · 2015-02-25FDA Approved: ALEVE PM — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application for Aleve PM (diphenhydramine hydrochloride and naproxen sodium) from Bayer HealthCare LLC. The …
-
FDA approval · 2015-02-16FDA Approved: LUNESTA — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for LUNESTA (eszopiclone) submitted by Waylis Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Internet-CBT (Cognitive Behavioral Therapy) for Depression and Anxiety in Parkinsons Disease [Phase 3]
A Phase 3 trial evaluating Internet-based Cognitive Behavioral Therapy for depression and anxiety in Parkinson's disease has completed.
-
FDA approval · 2015-02-13FDA Approved: ESZOPICLONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for eszopiclone filed by Mylan Pharmaceuticals Inc., signaling a modification to the existing approv…
-
CLINICAL_TRIALS withdrawal · 2015-02-10Clinical Trial Update: To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures [Phase 4]
A Phase 4 clinical trial evaluating the effect of perampanel on sleep in individuals with insomnia and partial-onset epilepsy has been withd…
-
CLINICAL_TRIALS trial_result · 2015-02-03Clinical Trial Update: Telephone Care Management to Address Sleep Problems in Young Children With Autism [Phase 2]
A Phase 2 clinical trial evaluating telephone care management to address sleep problems in young children with autism has completed.
-
FDA approval · 2015-01-30FDA Approved: ESZOPICLONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for eszopiclone filed by Sun Pharmaceutical Industries, Inc., signaling approval of a regulatory…
-
CLINICAL_TRIALS trial_result · 2015-01-30Clinical Trial Update: Safety and Pharmacokinetic Study of Sublingual Flumazenil (CRLS035) in Healthy Adults [Phase 1]
Phase 1 safety and pharmacokinetic study of sublingual flumazenil (CRLS035) in healthy adults has completed.
-
FDA approval · 2015-01-30FDA Approved: ESZOPICLONE — Original Application (Macleods Pharmaceuticals Limited)
The FDA approved Macleods Pharmaceuticals Limited's generic eszopiclone as an original ANDA for the treatment of insomnia. This marks the ap…
-
FDA approval · 2015-01-24FDA Approved: HYDROXYZINE PAMOATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva’s supplemental application for hydroxyzine pamoate, confirming its status as an approved generic drug. The action rela…
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED) [Phase 3]
This document reports the completion of a Phase 3 trial evaluating the efficacy and safety of MK0928 for insomnia in adults. It summarizes t…
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia (0928-006)(COMPLETED) [Phase 3]
A Phase 3 trial of MK0928 in healthy adult volunteers using a model of insomnia has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED) [Phase 3]
A Phase 3 clinical trial evaluating MK0928 in adult outpatients with insomnia has completed, sponsored by H. Lundbeck A/S.
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED) [Phase 3]
A Phase 3 clinical trial in adults with primary insomnia has completed the study.
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED) [Phase 2]
A Phase 2 clinical trial of MK0928 for adults with primary insomnia has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED) [Phase 3]
A Phase 3 trial for elderly patients with primary insomnia was terminated, with the study using polysomnography to assess outcomes.